Jean George - Feb 14, 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
/s/ David Gaiero, as attorney-in-fact for Jean George
Stock symbol
CYT
Transactions as of
Feb 14, 2024
Transactions value $
$23,914
Form type
4
Date filed
2/16/2024, 04:00 PM
Previous filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $23.9K +14.2K $1.69 14.2K Feb 14, 2024 Direct
holding CYT Common Stock 2.44M Feb 14, 2024 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -14.2K -100% $0.00* 0 Feb 14, 2024 Common Stock 14.2K $1.69 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person is a managing director of LSV Associates II, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein.